文献速递泌尿生殖与妇科肿瘤放疗

美国当代前列腺癌放射治疗:治疗模式与质量指标依从性

Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
PubMed 文献 · Pract Radiat Oncol · 2018-01-01

该研究纳入2011至2012年临床局限性前列腺癌男性患者,按D'Amico标准进行风险分层,评估其放疗模式及对2011年国家联盟认可的8项质量指标的依从性。926名接受根治性放疗的男性中,93%接受剂量递增外照射放疗(>75 Gy),但仅73%的外照射放疗和60%的近距离治疗符合质量指标,且非裔美国男性及其他少数族裔的依从性低于白人男性。

要点

  • 93%接受外照射放疗的患者接受剂量递增放疗(>75 Gy),95%采用常规分割(<2 Gy)。
  • 73%的外照射放疗符合质量指标,仅60%的近距离治疗符合质量指标。
  • 非裔美国男性(64%)和其他少数族裔(62%)的外照射放疗质量指标依从性低于白人男性(77%)。

核心结论

  • 多数接受放疗的局限性前列腺癌男性接受了适当的高剂量放疗,并接受了图像引导和调强放疗。
  • 然而,对某些国家认可质量指标的依从性相对较低,且依种族而异。
  • 改善放疗实施存在显著机会,尤其是对少数族裔男性。

研究设计与样本

  • 比较手术与放疗效果分析研究于2011年和2012年纳入临床局限性前列腺癌男性患者。
  • 患者完成问卷调查并查阅病历,按D'Amico分类标准进行风险分层。
  • 评估治疗模式及对截至2011年国家联盟认可的8项质量指标的依从性。

主要发现

  • 总体926名男性接受根治性放疗,其中69%接受外照射放疗(EBRT),17%接受近距离治疗(BT),14%接受外照射放疗联合近距离治疗,不同风险组间放疗技术差异显著。
  • 大多数接受外照射放疗的男性接受剂量递增外照射放疗(>75 Gy;93%),采用常规分割(<2 Gy;95%)、调强放疗(76%)和图像引导放疗(85%)。
  • 大多数接受近距离治疗的男性使用I125(77%)。
  • 总体73%的男性接受的外照射放疗符合质量指标(剂量递增、图像引导、雄激素剥夺治疗的适当使用和治疗靶区的适当性),但仅60%的男性接受的近距离治疗符合质量指标(植入后剂量测定和适当剂量)。
  • 非裔美国男性(64%)和其他少数族裔(62%)接受符合质量指标的外照射放疗的可能性低于白人男性(77%)。

关键数值与推荐

  • 外照射放疗符合质量指标的定义包括剂量递增、图像引导、雄激素剥夺治疗的适当使用和治疗靶区的适当性。
  • 近距离治疗符合质量指标的定义包括植入后剂量测定和适当剂量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Quality measures represent the standards of appropriate treatment agreed upon by experts in the field and often supported by data. The extent to which providers in the community adhere to quality measures in radiation therapy (RT) is unknown. METHODS AND MATERIALS: The Comparative Effectiveness Analysis of Surgery and Radiation study enrolled men with clinically localized prostate cancer in 2011 and 2012. Patients completed surveys and medical records were reviewed. Patients were risk-stratified according to D'Amico classification criteria. Patterns of care and compliance with 8 quality measures as endorsed by national consortia as of 2011 were assessed. RESULTS: Overall, 926 men underwent definitive RT (69% external beam radiation therapy [EBRT]), 17% brachytherapy (BT), and 14% combined EBRT and BT with considerable variation in radiation techniques across risk groups. Most men who received EBRT had dose-escalated EBRT (>75 Gy; 93%) delivered with conventional fractionation (<2 Gy; 95%), intensity modulated RT (76%), and image guided RT (85%). Most men treated with BT received I125 (77%). Overall, 73% of the men received EBRT that was compliant with the quality measures (dose-escalation, image-guidance, appropriate use of androgen deprivation therapy, and appropriate treatment target) but only 60% of men received BT that was compliant with quality measures (postimplant dosimetry and appropriate dose). African-American men (64%) and other minorities (62%) were less likely than white men (77%) to receive EBRT that was compliant with quality measures. CONCLUSIONS: Most men who received RT for localized prostate cancer were treated with an appropriately high dose and received image guidance and intensity modulated RT. However, compliance with some nationally recognized quality measures was relatively low and varied by race. There are significant opportunities to improve the delivery of RT and especially for men of a minority race.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lee DJ, Barocas DA, Zhao Z, et al. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures. Pract Radiat Oncol. 2018. PMID: 30177030. doi:10.1016/j.prro.2018.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。